Obsidio, Inc. is a medical device company pioneering an injectable solid biomaterial platform technology with broad applications in interventional radiology and interventional oncology. The Company's first product, Gel Embolic Material (GEM) is designed for controlled, precise, and durable peripheral vascular embolization
| Website | http://obsidiomed.com/ |
| Revenue | $598000 |
| Employees | 3 (0 on RocketReach) |
| Founded | 2018 |
| Address | 1502 Main St, Columbia, South Carolina 29201, US |
| Phone | +1 267-235-5951 |
| Industry | Manufacturing General, Medical, Manufacturing, Health Care |
| Keywords | Medical Devices, Interventional Radiology, Medical Technology, Innovative Medical Solutions, Interventional Oncology, Biomedical Technology, Minimally Invasive Procedures, Radiology Devices, Biocompatible Materials, Targeted Drug Delivery, Oncology Devices, Drug Delivery, Cancer Treatment |
| Competitors | Microsoft, Google, Evernote, Todoist, Trello, 스타트업 인사이드 ❘ Startup Inside, OneNote, Bear App, simpleapps.eu, Coggle +39 more (view full list) |
| SIC | SIC Code 382 Companies, SIC Code 38 Companies |
| NAICS | NAICS Code 339 Companies, NAICS Code 339112 Companies, NAICS Code 3391 Companies, NAICS Code 33 Companies, NAICS Code 33911 Companies |
Looking for a particular Obsidio, Inc. employee's phone or email?
Obsidio, Inc. Questions
The Obsidio, Inc. annual revenue was $598000 in 2026.
Obsidio, Inc. is based in Columbia, South Carolina.
The NAICS codes for Obsidio, Inc. are [339, 339112, 3391, 33, 33911].
The SIC codes for Obsidio, Inc. are [382, 38].
Related Companies
